These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 10606471)

  • 21. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
    J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late effects of Hodgkin's disease and its treatment.
    Ng AK; Mauch PM
    Cancer J; 2009; 15(2):164-8. PubMed ID: 19390314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late complications of therapy of Hodgkin's disease: prevention and management.
    Ng AK; Mauch PM
    Curr Hematol Rep; 2004 Jan; 3(1):27-33. PubMed ID: 14695846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of treating Hodgkin's disease without a policy of laparotomy staging.
    Bergsagel DE; Alison RE; Bean HA; Brown TC; Bush RS; Clark RM; Chua T; Dalley D; DeBoer G; Gospodarowicz M; Hasselback R; Perrault D; Rideout DF
    Cancer Treat Rep; 1982 Apr; 66(4):717-31. PubMed ID: 7074642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
    Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A
    J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
    Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of early stage primary tonsil non-Hodgkin's lymphoma].
    Gao YH; Li YX; Zhao LJ; Yuan ZY; Liu XF; Yu ZH
    Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):190-2. PubMed ID: 12864949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer risk following irradiation for Hodgkin's disease.
    Clemons M; Loijens L; Goss P
    Cancer Treat Rev; 2000 Aug; 26(4):291-302. PubMed ID: 10913384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Late treatment related complications of Hodgkin's disease].
    Henry-Amar M; Gisselbrecht C
    Rev Prat; 1998 May; 48(10):1092-7. PubMed ID: 9781154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Breast cancer after mantle field irradiation for Hodgkin's disease].
    Katz A; Brenner B; Sulkes A; Luria H; Marshak G; Fenig E
    Harefuah; 2000 May; 138(10):823-5, 911. PubMed ID: 10883245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary treatment of advanced Hodgkin's disease].
    Illés A; Udvardy M; Molnár Z
    Orv Hetil; 2005 Jan; 146(5):195-202. PubMed ID: 15773586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACR Appropriateness Criteria on Hodgkin's lymphoma: favorable prognosis stage I and II.
    Das P; Ng A; Constine LS; Hodgson DC; Mendenhall NP; Morris DE; Yunes MJ; Chauvenet AR; Hudson MM; Winter JN
    J Am Coll Radiol; 2008 Oct; 5(10):1054-66. PubMed ID: 18812149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Secondary breast cancer after treatment for Hodgkin's disease. About seven cases].
    Ben Hassouna J; Slimène M; Boussen H; Bouzaiene H; Khomsi F; Chargui R; Kochbati L; Mtaallah MH; Gamoudi A; Benna F; Hechiche M; Rahal K
    Gynecol Obstet Fertil; 2007 Jun; 35(6):536-40. PubMed ID: 17543568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late complications of Hodgkin's disease management.
    Young RC; Bookman MA; Longo DL
    J Natl Cancer Inst Monogr; 1990; (10):55-60. PubMed ID: 2189477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid second cancers following Hodgkin's disease.
    Tucker MA
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):389-400. PubMed ID: 8468272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hodgkin's lymphoma: problems in the treatment of the early stages].
    Bacigalupo A; Barra S; Corvò R; Guenzi M; Scolaro T; Vitale V
    Radiol Med; 1996 Nov; 92(5):620-3. PubMed ID: 9036456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of early-stage Hodgkin's disease.
    Advani RH; Horning SJ
    Semin Hematol; 1999 Jul; 36(3):270-81. PubMed ID: 10462327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.